VAC14 anticorps

N° du produit ABIN7120699

Détail du produit anti-VAC14 anticorps

Antigène: VAC14 (Vac14 Homolog (VAC14))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VAC14 est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC)

Purification: Immunogen affinity purified

Pureté: ≥95 % as determined by SDS-PAGE

Immunogène: Vac14 homolog

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:5000, IP: 1:200-1:2000,IHC: 1:20-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Date de péremption: 12 months

Détails sur VAC14

Antigène: VAC14 (Vac14 Homolog (VAC14))

Autre désignation: VAC14 (VAC14 Produits)

Sujet: Synonyms:ArPIKfyve, FLJ10305, FLJ36622, FLJ46582, Protein VAC14 homolog, Tax1 binding protein 2, TAX1BP2, TRX, VAC14, Vac14 homolog(S. cerevisiae) Background:The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate(PtdIns(3,5)P2). Acts as a positive activator of PIKfyve kinase activity. Also required to maintain normal levels of phosphatidylinositol 3-phosphate(PtdIns(3)P) and phosphatidylinositol 5-phosphate(PtdIns(5)P). Plays a role in the biogenesis of endosome carrier vesicles(ECV) / multivesicular bodies(MVB) transport intermediates from early endosomes.

Poids moléculaire: 88 kDa,65 kDa

ID gène: 55697

UniProt: Q08AM6

Pathways: Inositol Metabolic Process